Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986205 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric Oxygen for Traumatic and Non-traumatic Brain Injury
A Phase 2 study, sponsored by Lindell Weaver.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT01986205: Completed Phase 2 study, sponsored by Lindell Weaver.
NCT01986205 is a Phase 2 study that has completed, run by Lindell Weaver. The registered enrollment target is 49 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01986205, a Phase 2 study, has completed, sponsored by Lindell Weaver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether 40 hyperbaric oxygen sessions has effect on long-term symptoms after brain injury. This study will enroll 90 individuals with persistent problems 6 months to 10 years after a brain injury. These individuals will be randomized to receive either oxygen or air in a pressurized hyperbaric chamber. Participants will receive 40 daily hyperbaric chamber sessions. Participants will have a series of tests and questionnaires before they begin their chamber sessions, after they complete 40 sessions, and 6 months after they joined the study. These tests include computer-based and pencil-and-paper questionnaires and thinking tests, brain imaging, a neurological examination, and an eye exam. Participants will also be asked to provide blood for future research. After the 6-month tests are complete, all participants will receive 40 hyperbaric oxygen sessions, then undergo the same tests at 9 months and 12 months.
Primary Outcome
Participant-reported symptom rating of post-concussive symptoms
Interventions
- COMBINATION_PRODUCT Hyperbaric Oxygen
- COMBINATION_PRODUCT Minimal pressure air
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 2 |
What the finished NCT01986205 record still lists
NCT01986205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen is the first listed.
NCT01986205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01986205 about?
NCT01986205 is a clinical study titled "Hyperbaric Oxygen for Traumatic and Non-traumatic Brain Injury". The purpose of this study is to examine whether 40 hyperbaric oxygen sessions has effect on long-term symptoms after brain injury. This study will enroll 90 individuals with persistent problems 6 months to 10 years after a brain injury. These individuals will be randomized to receive either oxygen o...
What is the current status of trial NCT01986205?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2017-09-06. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT01986205?
The interventions under investigation include: Hyperbaric Oxygen (COMBINATION_PRODUCT), Minimal pressure air (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT01986205?
This trial is sponsored by Lindell Weaver, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01986205's enrollment target sits among peer trials
49 1261st of 2000 higher than 736 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI